홈 › 버킷 림프종 › 오하이오 › Cincinnati
OH Cincinnati의 버킷 림프종 임상 시험
버킷 림프종 관련 연구 12개가 Cincinnati 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
피험자 모집 중2상
- Cincinnati Children's Hospital Medical Center, Cincinnati
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
피험자 모집 중2상
- Cincinnati Children's Hospital Medical Center, Cincinnati
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
피험자 모집 중2상
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15마일 거리
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
피험자 모집 중3상
- University of Cincinnati Medical Center, Cincinnati
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
피험자 모집 중3상
- Cincinnati Children's Hospital Medical Center (Data Collection Only), Cincinnati
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
피험자 모집 중3상
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15마일 거리
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
피험자 모집 중2상
- Cincinnati Children's Hospital Medical Center, Cincinnati
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
피험자 모집 중3상
- Cincinnati Children's Hospital Medical Center, Cincinnati
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
피험자 모집 중2상
- Cincinnati Children's Hospital Medical Center, Cincinnati
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
피험자 모집 중관찰 연구
- Cincinnati Children's Hospital Medical Center, Cincinnati
Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALL
피험자 모집 중1상
- Cincinnati Children's Hospital Medical Center, Cincinnati
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
피험자 모집 중1상
- University of Cincinnati, Cincinnati
다른 도시의 버킷 림프종 시험
- Houston, TX연구 21개
- Milwaukee, WI연구 16개
- Philadelphia, PA연구 16개
- New York City, NY연구 14개
- Seattle, WA연구 13개
- Chicago, IL연구 13개
- Atlanta, GA연구 11개
- Aurora, CO연구 10개
- Boston, MA연구 10개
- Kansas City, MO연구 10개
- Durham, NC연구 10개
- Los Angeles, CA연구 10개
Cincinnati의 다른 연구
- 비소세포폐암연구 35개
- 암 (전체)연구 28개
- 유방암연구 25개
- 심부전연구 24개
- 대장직장암연구 21개
- 비만연구 20개
- 전이성 암연구 20개
- 급성 골수성 백혈병연구 20개
- 폐암연구 19개
- 난소암연구 19개
- 전립선암연구 18개
- 흑색종연구 17개
ClinicalTrials.gov 출처, 2026. 9. 29. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.